Navigation Links
Old is gold– proved yet another tim

Chloroquine, an antimalarial drug was highly successful in combating the disease when launched in the 1950s.// It soon became useless because of resistance being developed by the malarial parasite.

Scientists have found a way to breathe new life into the drug. It has been found that combining the drug with another preparation, Primaquine, would restore the effect of the original drug.

Malaria is caused by the parasite Plasmodium falciparum and is associated with a significant mortality all over the world, especially in the developing countries.

Chloroquine - which is far cheaper than more modern malaria drugs - works by blocking the way the parasite breaks down human hemoglobin contained in red blood cells. If the haem molecules remain in an uncrystallised form, they are toxic to the parasite, thereby killing it.

On its own, primaquine has no effect on P. falciparum, but it is structurally similar to chloroquine. The right concentration and combination of Primaquine and Chloroquine has been found to be effective on chloroquine-resistant parasites.

It is believed that that the drug combination would work better as chloroquine would be prevented from leaking out by a parallel action of primaquine that acts to block the pores on the surface of the parasite's digestive system The finding promises hope and would be less expensive when compared to the existing treatment. This would also ensure that it is made available the poorest countries where need is greatest.

However, caution has to be taken because primaquine is not suitable for all patients, as it could trigger the break down of red blood cells in people with an enzyme deficiency. People would have to be tested for the same before the therapy can be instituted.
'"/>




Page: 1

Related medicine news :

1. Abortion Pill approved by FDA
2. Another injectable contraceptive Pill approved by FDA
3. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
4. New FDA Approved Drug To Treat Migraine
5. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
6. New FDA Approved Drug NATRECOR For Heart Failure Patients
7. Voice may be improved by surgery
8. New oral antiviral treatment of cold sores approved
9. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
10. ICU Survival can be improved by Antibiotic use
11. Survival rate not improved by invasive procedures
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/29/2017)... ... May 29, 2017 , ... The ... program for Recovery Coaches who are seeking opportunities to provide recovery support services ... centers, and others. Recovery Coaching and Professionalism© was created in response to the ...
(Date:5/29/2017)... ... May 29, 2017 , ... ... in Springfield, Illinois, is the new president of the Board of Directors for ... for radiology practice administrators. He succeeds outgoing Board President Jim Hamilton, MHA, CMM, ...
(Date:5/28/2017)... ... May 28, 2017 , ... Starting in May, patients at The Bay ... Variability (HRV) diagnostic test. , Nerve-Express, originally designed for the Navy in the 1980s, ... of a patient’s autonomic nervous system (ANS). The ANS controls all the critical ...
(Date:5/28/2017)... Winter Haven, FL (PRWEB) , ... May 28, ... ... Physician Partners of America (PPOA), is proud to announce that Sheldon K. Cho, ... on comprehensive interventional pain management, a specialty that concentrates on minimally invasive techniques ...
(Date:5/27/2017)... TX (PRWEB) , ... May 27, 2017 , ... Hate visiting the dentist? You should ... you'll need to take care of your teeth at home. Here are some dental tips ... after meals. Keep a small toothbrush in your work desk or a locker at school ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... , May 4, 2017  Fortuna Fix Inc. (" ... to be the first to eliminate the need for embryonic ... cells to treat neurodegenerative diseases. Fortuna ... with Professor Michael Fehlings , MD, PhD; Father ... , MD, MPH; and Professor James Giordano , PhD. ...
(Date:5/4/2017)... SAN DIEGO , May 4, 2017 /PRNewswire/ ... Annual Clinical and Scientific Meeting— OBP Medical , a ... today announced the launch of a new extra-small size ... and ER-SPEC vaginal specula. Already available in ... extra-large sizes makes OBP Medical,s line of single-use lighted ...
(Date:5/4/2017)... BOTHELL, Wash. , May 4, 2017   ... a leading developer, manufacturer and marketer of proprietary clinical ... media ("BioLife" or the "Company"), today announced that ... released after market close on Thursday, May 11, 2017, ... and live webcast at 1:30 p.m. PT that afternoon. ...
Breaking Medicine Technology: